Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Haltha is an online matching platform for paid clinical trials. Its core goal is to help individual participants find medical studies nearby or studies that match their profile, while also helping life sciences organizations with patient recruitment. According to the site, its founding vision is to use digital tools to serve the U.S. pharmaceutical industry by connecting clinical trials, participants, and industry partners.
The platform offers free registration, profile creation, browsing of Live Studies, and trial filtering by location, compensation, study duration, trial phase, or keyword. Users can look for matching studies based on eligibility criteria such as age, health conditions, medical history, and current medications, then follow the provided instructions after selecting a study. The site also includes educational content about clinical trials, FAQs, compensation explanations, and participation process guides, making it easier for general users to understand how trials work.
Haltha emphasizes “Sign Up for Free” for participants, meaning registration is free. Pricing for its business-side plans, institutional fees, or SaaS subscriptions is not disclosed. Participant compensation depends on the type and duration of the study: short-term studies are typically around $100-500, mid-term studies around $500-2,000, and long-term studies around $2,000-5,000 or more. Payments may be made at the first visit, at milestones, and upon study completion.
The platform states that clinical trials require IRB approval, regulatory compliance, and ongoing safety monitoring. Its FAQ mentions the regulatory roles of the U.S. FDA, independent ethics committees, and institutional review boards. The privacy policy discloses that it collects names, email addresses, addresses, health conditions, medication information, device data, and site interaction data, and may share information with clinical trial organizations when a user qualifies for a study. Its security measures include SSL, password-protected servers, and administrator access controls. It also provides information about CCPA and GDPR-related rights, while explicitly noting that internet transmission cannot be guaranteed to be absolutely secure.
The strengths are a clear registration and participation flow, practical trial filtering options, and relatively transparent explanations of compensation and safety. The drawbacks are limited disclosure of business-side SaaS capabilities, with no visible details on team permissions, customer dashboards, API documentation, specific third-party integrations, or institutional pricing. It is better suited to individuals who want to apply for U.S. clinical trials, as well as life sciences organizations that need a digital patient recruitment channel.
The site does not state whether users in mainland China can access the platform, make or receive payments, or participate in U.S. clinical trials, so feasibility is unknown. Since platform data is processed in the United States and clinical trials are usually subject to geographic, eligibility, and regulatory restrictions, Chinese users should first verify participation eligibility, cross-border privacy implications, and compensation payment methods. Alternatives or references include ClinicalTrials.gov, Antidote, TrialX, Power, CenterWatch, as well as China’s local drug clinical trial registration channels.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on halthaconnect.com official site.
halthaconnect.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach halthaconnect.com directly.